Guodong Liang | Medicinal | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. Guodong Liang | Medicinal | Young Scientist Award

Senior Engineer at Inner Mongolia Medical University, China

Summary:

Assoc Prof Dr Guodong Liang is a senior engineer and master tutor at the College of Pharmacy, Inner Mongolia Medical University. Specializing in peptide-based antiviral research, Dr. Liang completed his Bachelor’s and Master’s degrees at Shenyang Pharmaceutical University in 2012 and 2015, respectively, and earned his Ph.D. from the Beijing Institute of Pharmacology and Toxicology in 2018. His research focuses on innovative peptide fusion inhibitors for treating viral infections, including HIV-1 and SARS-CoV-2. Notable for his contributions to peptide science, Dr. Liang has published extensively, holds a U.S. patent, and has received funding from various prestigious programs.

 

Profile:

Education:

Assoc Prof Dr Guodong Liang earned his Bachelor’s degree in Pharmacy from Shenyang Pharmaceutical University in 2012. He continued his studies at the same institution, obtaining a Master’s degree in Pharmaceutical Sciences in 2015. Further advancing his academic career, he completed his Ph.D. in Pharmacology and Toxicology at the Beijing Institute of Pharmacology and Toxicology in 2018. His educational background has provided a strong foundation for his research in peptide-based antiviral strategies.

Professional Experience:

Assoc Prof Dr Guodong Liang is a senior engineer and master tutor at the College of Pharmacy, Inner Mongolia Medical University. In this role, he leads research and teaching initiatives, focusing on peptide-based antiviral therapies. Prior to his current position, Dr. Liang has accumulated extensive experience in peptide research and development. His expertise encompasses the design of peptide fusion inhibitors and contributions to significant research projects funded by various programs, including the Inner Mongolia Natural Science Foundation and Inner Mongolia Medical University. His professional background reflects a commitment to advancing antiviral research and educating the next generation of scientists.

Research Interests:

Assoc Prof Dr Guodong Liang’s research interests are centered around peptide-based antiviral therapies. His work primarily focuses on the development and application of peptide fusion inhibitors to combat viral infections. Notable areas of his research include the design of isopeptide bond bundling superhelixes and their application in creating inhibitors against viruses such as HIV-1 and SARS-CoV-2. Dr. Liang explores innovative methods for developing broad-spectrum antiviral peptide drugs, aiming to enhance the efficacy of treatments for various viral diseases. His research integrates advanced peptide chemistry with practical antiviral applications, contributing to the field of pharmaceutical science.

Skills:

Assoc Prof Dr Guodong Liang possesses a robust skill set in peptide chemistry and antiviral drug development. His expertise includes designing and synthesizing peptide-based fusion inhibitors, with a focus on creating isopeptide bond bundling superhelixes for antiviral applications. Dr. Liang is proficient in advanced techniques for peptide analysis and evaluation, including structural and functional assessments of peptide interactions with viral proteins. His skills extend to securing and managing research funding, conducting collaborative projects, and publishing high-impact scientific papers. With a strong foundation in pharmacology and toxicology, Dr. Liang effectively translates complex scientific concepts into practical antiviral solutions.

Conclution:

Dr. Liang’s pioneering work in peptide-based antiviral research, evidenced by his impactful publications, patents, and innovative projects, demonstrates his significant contributions to the field. His research not only advances the design of targeted antiviral therapies but also lays the groundwork for developing broad-spectrum antiviral drugs, marking him as a leading candidate for the Research for Young Scientist Award.

Publication Tob Noted:

A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity

  • Authors: Li, Y.-Y., Liang, G.-D., Chen, Z.-X., Liu, S.-W., Yang, J.
  • Journal: Acta Pharmacologica Sinica, 2024

Isopeptide Bond Bundling Superhelix for Designing Antivirals against Enveloped Viruses with Class I Fusion Proteins: A Review

  • Authors: Na, H., Liang, G., Lai, W.
  • Journal: Current Pharmaceutical Biotechnology, 2023, 24(14), pp. 1774–1783

Hipponorterpenes A and B, two new 14-noreudesmane-type sesquiterpenoids from the juice of Hippophae rhamnoides

  • Authors: Zhang, X.-L., Na, H.-Y., Li, P.-S., Liang, G.-D., Hua, H.-M.
  • Journal: Phytochemistry Letters, 2022, 52, pp. 82–86

De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery

  • Authors: Wang, C., Zhao, L., Xia, S., Jiang, S., Liu, K.
  • Journal: Journal of Medicinal Chemistry, 2018, 61(19), pp. 8734–8745

 

Kelly Yoo | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Kelly Yoo | Medicine | Best Researcher Award

Clinician Scientist at Stanford University, United States

Summary:

Dr. Kelly Yoo, M.D., Ph.D., is a distinguished neurosurgeon and postdoctoral fellow at Stanford University School of Medicine. She began her education at Yeomdong Elementary School in Seoul, South Korea, where she was recognized as a top student in the gifted class. She continued her studies at the International School of Hamburg in Germany, earning an International Baccalaureate (IB) Diploma with distinction. Dr. Yoo pursued her medical education at Heidelberg University School of Medicine, excelling academically and completing her MD/PhD program with top honors. Her doctoral research focused on enhancing CAR T cell therapy for B cell malignancies, earning her a Magna cum laude distinction. Dr. Yoo’s residency training includes positions at Heidelberg University Hospital, Klinikum of Ludwig-Maximilians-University of Munich, and University Medical Center Freiburg, consistently ranking among the top of her peers. Since September 2022, she has been advancing her research and clinical expertise as a postdoctoral fellow at Stanford. In addition to her medical career, Dr. Yoo is dedicated to mentoring and teaching, having co-founded MedSchool Mentor to support future medical professionals. Her contributions to education and research have established her as a prominent figure in neurosurgery and oncology.

Profile:

Education:

Dr. Kelly Yoo began her academic journey at Yeomdong Elementary School in Seoul, South Korea, where she was a school representative and part of the gifted class with an IQ of 145, earning a Certificate of Distinction for being in the top 0.1%. She continued her education at Yeomgyeong Middle School, also in Seoul, before moving to Germany to attend the International School of Hamburg. There, she completed the International Baccalaureate (IB) Diploma, received a Certificate of Distinction for being in the top 0.1%, and participated in grade acceleration and gifted education. Dr. Yoo pursued her medical studies at Heidelberg University School of Medicine from October 2012 to October 2019. She excelled in her academic performance, consistently ranking in the top 1% of her class and achieving top 10% marks in her medical state examinations. She completed the MD/PhD Program at Heidelberg University, earning her German Medical License (Approbation) in November 2019. Her doctoral research at the Department of Internal Medicine V / Hematology Oncology at Heidelberg University Hospital focused on tumor-specific reactive oxygen species accelerators to improve Chimeric Antigen Receptor (CAR) T cell therapy in B cell malignancies, for which she received a Magna cum laude distinction. Additionally, Dr. Yoo furthered her education through various programs and internships at Johns Hopkins University, Seoul National University Hospital, and Thoraxklinik at Heidelberg University Hospital, among others.

Professional Experience:

Dr. Kelly Yoo has built an impressive professional career in neurosurgery and oncology. She began her residency in neurosurgery at Kopfklinik, Heidelberg University Hospital (UKHD), where she ranked in the top 1% of her peers. She then completed a residency in radiation oncology at Klinikum of Ludwig-Maximilians-University of Munich, achieving top 10% recognition. Returning to neurosurgery, she pursued further residency training at University Medical Center Freiburg (UKF), where she distinguished herself in the top 0.1%. Since September 2022, Dr. Yoo has been a postdoctoral fellow in the Department of Neurosurgery at Stanford University School of Medicine. In this role, she continues to advance her research and clinical expertise, contributing to cutting-edge developments in neurosurgery. Her dedication to excellence is evident throughout her career, from her clinical practice to her commitment to mentoring and teaching the next generation of medical professionals.

Research Interest:

Dr. Kelly Yoo’s research interests are deeply rooted in advancing the fields of neurosurgery and oncology. Her doctoral research focused on enhancing Chimeric Antigen Receptor (CAR) T cell therapy for B cell malignancies by using tumor-specific reactive oxygen species accelerators, a project that earned her a Magna cum laude distinction. She is particularly interested in the intersection of immunotherapy and neurosurgery, aiming to develop innovative treatments that improve patient outcomes in malignant and non-malignant brain disorders. At Stanford University, Dr. Yoo continues to explore cutting-edge therapies and techniques, with a commitment to translating her research findings into clinical applications that can benefit patients globally. Her work is characterized by a dedication to precision medicine and the use of advanced neuroimaging and neuromonitoring technologies to enhance the effectiveness and safety of neurosurgical procedures.

Awards and Honors:

Dr. Kelly Yoo has garnered numerous awards and honors throughout her distinguished career. In her early education, she was recognized as part of the gifted class at Yeomdong Elementary School and received a Certificate of Distinction for being in the top 0.1% of her peers. During her high school years at the International School of Hamburg, she earned another Certificate of Distinction for her exceptional performance in the International Baccalaureate (IB) program. Her academic excellence continued at Heidelberg University School of Medicine, where she consistently ranked in the top 1% of her class and achieved top 10% marks in her medical state examinations. Her groundbreaking doctoral research on enhancing CAR T cell therapy for B cell malignancies earned her a Magna cum laude distinction. In her professional career, Dr. Yoo received Certificates of Empowerment for being among the top residents at Kopfklinik, Heidelberg University Hospital, Klinikum of Ludwig-Maximilians-University of Munich, and University Medical Center Freiburg. These accolades reflect her outstanding contributions to neurosurgery and oncology, underscoring her dedication to clinical excellence and innovative research.

Publication:

The Role of CyberKnife Stereotactic Radiosurgery in Recurrent Cranial Medulloblastomas across Pediatric and Adult Populations

  • Authors: K.H. Yoo, N.J. Marianayagam, D.J. Park, … A. Meola, S.D. Chang
  • Journal: Journal of Clinical Medicine
  • Year: 2024
  • Volume: 13(12)
  • Page: 3592
  • Citations: 0

Therapeutic approaches for spinal synovial sarcoma: a comprehensive review of the literature

  • Authors: A. Zamarud, S. Shahnoor, A. Maryyum, … D.J. Park, S.D. Chang
  • Journal: Journal of Neurosurgery: Spine
  • Year: 2024
  • Volume: 40(6)
  • Pages: 782-789
  • Citations: 0

Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review

  • Authors: A. Zamarud, N.J. Marianayagam, V. Sekar, … S.D. Chang, A. Meola
  • Journal: Journal of Neurosurgery: Spine
  • Year: 2024
  • Volume: 40(4)
  • Pages: 485-497
  • Citations: 0

Stereotactic Radiosurgery for Cranial and Spinal Hemangioblastomas: A Single-Institution Retrospective Series

  • Authors: K.H. Yoo, D.J. Park, N.J. Marianayagam, … S.D. Chang, A. Meola
  • Journal: Neurosurgery
  • Year: 2024
  • Volume: 94(3)
  • Pages: 630-642
  • Citations: 1

Evaluating Computer Vision, Large Language, and Genome-Wide Association Models in a Limited Sized Patient Cohort for Pre-Operative Risk Stratification in Adult Spinal Deformity Surgery

  • Authors: E. Schonfeld, A. Pant, A. Shah, … G. Haider, A. Veeravagu
  • Journal: Journal of Clinical Medicine
  • Year: 2024
  • Volume: 13(3)
  • Page: 656
  • Citations: 0

The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience

  • Authors: A. Zamarud, N.J. Marianayagam, D.J. Park, … A. Meola, S.D. Chang
  • Journal: Journal of Neuro-Oncology
  • Year: 2023
  • Volume: 165(2)
  • Pages: 373-379
  • Citations: 2

Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation

  • Authors: A. Zamarud, D.J. Park, T.H. Ung, … S.D. Chang, A. Meola
  • Journal: World Neurosurgery
  • Year: 2023
  • Volume: 179
  • Pages: e366-e373
  • Citations: 1

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

  • Authors: K.H. Yoo, D.J. Park, J.H. Choi, … A. Meola, S.D. Chang
  • Journal: Frontiers in Oncology
  • Year: 2023
  • Volume: 13
  • Article: 1223599
  • Citations: 3

Stereotactic radiosurgery for distant brain metastases secondary to esthesioneuroblastoma: a single-institution series

  • Authors: A. Zamarud, U. Yener, K.H. Yoo, … S.D. Chang, A. Meola
  • Journal: Neurosurgical Focus
  • Year: 2023
  • Volume: 55(2)
  • Article: E6
  • Citations: 1

Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience

  • Authors: A. Zamarud, D.J. Park, D.Y.A. Dadey, … S.D. Chang, A. Meola
  • Journal: Neurosurgical Focus
  • Year: 2023
  • Volume: 55(2)
  • Article: E7
  • Citations: 1

 

Addis Eyeberu | Health Sciences Award | Best Researcher Award

Posted on by ScienceFather

Mr. Addis Eyeberu, Health Sciences Award, Best Researcher Award

Addis Eyeberu at Haramaya University, Ethiopia

Mr. Addis Eyeberu holds a Master of Science in Maternal and Neonatal Nursing from Haramaya University, Ethiopia, completed in August 2020, with a CGPA of 3.99 out of 4. He also earned a Bachelor of Science in Midwifery from Haramaya University, completed in July 2016, with a CGPA of 3.89. Additionally, he participated in Higher Diploma Programs at Haramaya University in September 2016. Mr. Eyeberu has been involved in various roles such as Assistant Lecturer, Coordinator, and Project Coordinator at Haramaya University, Ethiopia, with a focus on adolescent health, maternal and neonatal health, and community-based educational programs. He is experienced in research, data management, report writing, and research methodology, having collaborated with sub-Saharan African country researchers and Harvard University researchers on projects funded by the Botnar Foundation and Haramaya University.

Profile:

Education:

Mr. Addis Eyeberu holds a Master of Science in Maternal and Neonatal Nursing from Haramaya University, Ethiopia, completed in August 2020, with a CGPA of 3.99 out of 4. He also earned a Bachelor of Science in Midwifery from Haramaya University, completed in July 2016, with a CGPA of 3.89. Additionally, he participated in Higher Diploma Programs at Haramaya University in September 2016.

Professional Experience:

Mr. Addis Eyeberu has a diverse professional experience in the healthcare and academic sectors. He started his career as a member of the Ethiopian Midwifery Association in 2012 and served as a GA II at Haramaya University from 2016 to 2017. He then progressed to become an Assistant Lecturer at Haramaya University from 2018 to 2020. During this time, he also took on roles such as Coordinator for Problem-Based Learning (PBL) and supervised Community-Based Educational programs. From 2020 to 2022, Mr. Eyeberu served as a Project Coordinator for the ARISE project supervised by Harvard University and continued as a Masters Students advisor until September 2023. He also took on leadership roles as the Chairperson of Accreditation of the Midwifery Program at Haramaya University from 2022 to 2023. Overall, Mr. Eyeberu’s professional journey reflects his commitment to healthcare, education, research, and leadership in various capacities.

Research Interest:

Mr. Addis Eyeberu’s research interests include a broad spectrum of topics related to healthcare and public health, with a specific focus on maternal and neonatal health, adolescent health, and community-based healthcare interventions. His research areas encompass neonatal mortality, labor pain management, burdens of maternal infections, essential newborn care practices, and adolescent health risk behaviors. Additionally, Mr. Eyeberu is interested in studying herbal use during pregnancy and childbirth, food taboos, and the functionality of Maternity Waiting Homes (MWH) in Ethiopia. His research endeavors aim to contribute to improving healthcare outcomes, particularly in vulnerable populations such as mothers, newborns, and adolescents, through evidence-based interventions and policies.

Publication Top Noted:

Neonatal mortality among neonates admitted to NICU of Hiwot Fana specialized university hospital, eastern Ethiopia, 2020: a cross-sectional study design

  • Authors: A. Eyeberu, H. Shore, T. Getachew, G. Atnafe, M. Dheresa
  • Published in: BMC Pediatrics
  • Year: 2021
  • Cited By: 26

Health status of street children and reasons for being forced to live on the streets in Harar, Eastern Ethiopia. Using mixed methods

  • Authors: D. Abate, A. Eyeberu, D. Adare, B. Negash, A. Alemu, T. Beshir, …
  • Published in: Plos One
  • Year: 2022
  • Cited By: 15

Community risk perception and health-seeking behavior in the era of COVID-19 among adult residents of Harari regional state, eastern Ethiopia

  • Authors: A. Eyeberu, DA. Mengistu, B. Negash, A. Alemu, D. Abate, TB. Raru, …
  • Published in: SAGE Open Medicine
  • Year: 2021
  • Cited By: 11

Acceptance of COVID-19 vaccine and associated factors among health care workers at public hospitals in Eastern Ethiopia using the health belief model

  • Authors: T. Getachew, M. Lami, A. Eyeberu, B. Balis, A. Debella, B. Eshetu, M. Degefa, …
  • Published in: Frontiers in Public Health
  • Year: 2022
  • Cited By: 9

Maternal satisfaction on delivery care services and associated factors at public hospitals in eastern Ethiopia

  • Authors: A. Kidane, T. Getachew, F. Mesfin, A. Eyeberu, M. Dheresa
  • Published in: International Health
  • Year: 2023
  • Cited By: 8

 

Wolnei Caumo | Medical award | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Wolnei Caumo, Medical Award, Best Researcher Award

Professor at UFRGS, Brazil

Prof. Dr. Wolnei Caumo is a distinguished expert in the fields of anesthesia, pain management, and clinical research. As the Director of the Pain & Neuromodulation Laboratory at Hospital de Clínicas de Porto Alegre (HCPA) and Full Professor of Anesthesia and Pain at the Medical School of Universidade Federal do Rio Grande do Sul (UFRGS) in Porto Alegre, Brazil, he has made significant contributions to advancing the understanding and treatment of chronic pain conditions. Dr. Caumo’s research focuses on neurophysiological markers of pain processing, biomarkers of neuroplasticity in chronic pain, and therapeutic interventions such as pharmacological and non-invasive brain stimulation techniques. He is renowned for his dedication to education and mentorship, guiding numerous students and research fellows in pain management practices. Dr. Caumo’s work has earned him widespread recognition and respect, and he continues to lead innovative research efforts aimed at improving the lives of individuals living with chronic pain.

Profile:

Education:

  • M.D. from Universidade Federal de Pelotas, Brazil (1992)
  • Residency in Anesthesia at Hospital de Clínicas de Porto Alegre, Brazil (1994)
  • M.Sc. in Medicine from Universidade Federal do Rio Grande do Sul, Brazil (1997)
  • Specialist in Pain and Palliative Medicine from Universidade Federal do Rio Grande do Sul, Brazil (2000)
  • Ph.D. in Medicine with specialization in Pain from Universidade Federal do Rio Grande do Sul, Brazil (2001)
  • Clinical Research Course from Harvard Medical School, USA (2011)

Professional Experience:

Prof. Dr. Wolnei Caumo holds several prominent positions in the field of anesthesia, pain management, and research. He is currently serving as a Full Professor of Anesthesia and Pain at the Medical School of Universidade Federal do Rio Grande do Sul in Porto Alegre, Brazil, a position he has held since 2003. Additionally, he serves as the Head of Service in Pain and Palliative Care at Hospital de Clínicas de Porto Alegre, where he has been contributing since 2017. Dr. Caumo is also the Director of the Laboratory of Pain & Neuromodulation at the same hospital, a role he has held since 2009. Over the years, he has been actively involved in coordinating various academic programs, including the Specialized Medical Care for Pain and Palliative Medicine Course and the Graduate Program in Medical Sciences at Universidade Federal do Rio Grande do Sul. Furthermore, he has been a Coordinator of the Center and teacher assistance of the Course in Principles and Practice of Clinical Research at Harvard Medical School since 2012. Dr. Caumo’s dedication to education and research in pain management has made him a respected figure in the field, both nationally and internationally.

Research Interest:

Prof. Dr. Wolnei Caumo’s research interests primarily revolve around pain management and neuromodulation approaches. He is particularly focused on investigating the neurophysiological mechanisms underlying chronic pain processing, including central sensitization and cortical excitability. Dr. Caumo’s research aims to identify biomarkers of neuroplasticity in musculoskeletal chronic pain conditions and explore therapeutic interventions to counteract maladaptive neuroplasticity. Additionally, he is interested in the therapeutic potential of non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), in modulating pain perception and improving clinical outcomes in patients with chronic pain syndromes. His work also encompasses the evaluation of pharmacological interventions and the development of personalized treatment approaches based on individual neurobiological profiles. Overall, Prof. Dr. Wolnei Caumo’s research endeavors contribute to advancing our understanding of pain mechanisms and developing innovative strategies for pain management.

Publication Top Noted:

“Cross-sectional and longitudinal analysis of conditioned pain modulation and pain in fibromyalgia: CPM as an effect modifier of pain changes over time”:

  • Authors: Castelo-Branco, L., Pacheco-Barrios, K., Cardenas-Rojas, A., Caumo, W., Fregni, F.
  • Journal: Physiotherapy Research International
  • Year: 2024
  • Volume: 29
  • Issue: 2
  • Pages: e2072

“Impact of multiple-session home-based transcranial direct current stimulation (M-HB-tDCS) on eating behavior in fibromyalgia: A factorial randomized clinical trial”:

  • Authors: Jornada, M.N.D., Antunes, L.C., Alves, C., P Silva, D., Caumo, W.
  • Journal: Brain Stimulation
  • Year: 2024
  • Volume: 17
  • Issue: 2
  • Pages: 152–162

“Efficacy of Home-Based Transcranial Direct Current Stimulation Over the Primary Motor Cortex and Dorsolateral Prefrontal Cortex in the Disability Due to Pain in Fibromyalgia: A Factorial Sham-Randomized Clinical Study”:

  • Authors: Caumo, W., Lopes Ramos, R., Vicuña Serrano, P., LS Torres, I., Fregni, F.
  • Journal: Journal of Pain
  • Year: 2024
  • Volume: 25
  • Issue: 2
  • Pages: 376–392

“Troponin elevation as a marker of short deterioration and one-year death in a high-risk surgical patient cohort in a low and middle-income country setting: a postoperative approach to increase surveillance”:

  • Authors: Stahlschmidt, A., Passos, S.C., Dornelles, D.D., Caumo, W., Ferreira, M.
  • Journal: Canadian Journal of Anesthesia
  • Year: 2023
  • Volume: 70
  • Issue: 11
  • Pages: 1776–1788

“Transcranial Direct Current Stimulation (tDCS) Promotes state-dependent Effects on Neuroinflammatory and Behavioral Parameters in rats Chronically Exposed to Stress and a Hyper-Palatable Diet”:

  • Authors: de Castro, J.M., de Freitas, J.S., Stein, D.J., Caumo, W., Torres, I.L.S.
  • Journal: Neurochemical Research
  • Year: 2023
  • Volume: 48
  • Issue: 10
  • Pages: 3042–3054

“Preemptive transcranial direct current stimulation induces analgesia, prevents chronic inflammation and fibrosis, and promotes tissue repair in a rat model of postoperative pain”:

  • Authors: Zancanaro, M., Stein, D.J., Lopes, B.C., Caumo, W., Torres, I.L.S.
  • Journal: Neuroscience Letters
  • Year: 2023
  • Volume: 813
  • Pages: 137407